Literature DB >> 7299351

C-reactive protein is protective against Streptococcus pneumoniae infection in mice.

C Mold, S Nakayama, T J Holzer, H Gewurz, T W Du Clos.   

Abstract

C-reactive protein (CRP) has several properties that suggest that it may function as a bacterial opsonin. CRP shows binding reactivity with pneumococcal C-polysaccharide, the cell wall carbohydrate of Streptococcus pneumoniae. In this study we have demonstrated protection of mice against serotypes 3 and 4 of S. pneumoniae infection by a single prior injection of CRP. This effect was seen both in mice that lacked antibody to phosphocholine and in normal mice. Thus the opsonic properties of CRP previously described may be related to protection against pneumococcal infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7299351      PMCID: PMC2186532          DOI: 10.1084/jem.154.5.1703

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  The chemical composition of pneumococcal C-polysaccharide.

Authors:  T Y LIU; E C GOTSCHLICH
Journal:  J Biol Chem       Date:  1963-06       Impact factor: 5.157

2.  In vitro effects of C-reactive protein on phagocytosis.

Authors:  Y HOKAMA; M K COLEMAN; R F RILEY
Journal:  J Bacteriol       Date:  1962-05       Impact factor: 3.490

3.  Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria.

Authors:  C O Kindmark
Journal:  Clin Exp Immunol       Date:  1971-06       Impact factor: 4.330

4.  Studies of human C-reactive protein in an in vitro phagocytic system.

Authors:  R C Williams; P G Quie
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

5.  Mediation of CRP-dependent phagocytosis through mouse macrophage Fc-receptors.

Authors:  R F Mortensen; J A Duszkiewicz
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

6.  Degradation of a pneumococcal type-specific polysaccharide with exposure of group-specificity.

Authors:  J D Higginbotham; M Heidelberger; E C Gotschlich
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

7.  Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis.

Authors:  R F Mortensen; A P Osmand; T F Lint; H Gewurz
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

8.  Isolation of serum amyloid P-component (protein SAP) in the mouse.

Authors:  M B Pepys
Journal:  Immunology       Date:  1979-07       Impact factor: 7.397

9.  The role of the spleen in experimental pneumococcal bacteremia.

Authors:  E J Brown; S W Hosea; M M Frank
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

10.  THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : I. DISTRIBUTION OF THE REACTIVE PROTEIN IN PATIENTS' SERA AND THE EFFECT OF CALCIUM ON THE FLOCCULATION REACTION WITH C POLYSACCHARIDE OF PNEUMOCOCCUS.

Authors:  T J Abernethy; O T Avery
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

View more
  72 in total

1.  Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide.

Authors:  Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson; Alok Agrawal
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

2.  Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci.

Authors:  S C Szu; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

Review 3.  Molecular genetics, structure, and function of C-reactive protein.

Authors:  J M Kilpatrick; J E Volanakis
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice.

Authors:  A J Szalai; J L VanCott; J R McGhee; J E Volanakis; W H Benjamin
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 5.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

6.  Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.

Authors:  D E Briles; C Forman; J C Horowitz; J E Volanakis; W H Benjamin; L S McDaniel; J Eldridge; J Brooks
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

Review 7.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

8.  Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae.

Authors:  D S Chudwin; S G Artrip; A Korenblit; G Schiffman; S Rao
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy.

Authors:  M J Ridley; D S Ridley; F C De Beer; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

10.  Serum C-Reactive Protein (CRP), Target for Therapy or Trouble?

Authors:  Virginia B Kraus; Joanne M Jordan
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.